Obesity-related glomerulopathy: the defining pathology
Evidence tier
Established · ORG · Diagnostics
Plain-language summary
The lesion of glomerulomegaly and adaptive FSGS driven by hyperfiltration — the histologic signature that distinguishes obesity-related glomerulopathy from primary FSGS.
Key findings
- Kambham 2001: first large biopsy series defining O-FSGS and glomerulomegaly.
- D’Agati 2016: comprehensive review of clinical/pathologic characteristics and pathogenesis.
Population
Patients with obesity and proteinuric kidney disease on biopsy.
Primary source
Kambham N, et al. Kidney Int. 2001;59:1498–1509. · D’Agati VD, et al. Nat Rev Nephrol. 2016;12:453–471.
https://www.nature.com/articles/nrneph.2016.75
Educational only
Paraphrased from the primary publication; not individual medical advice. Verify against the source before applying to care.